[Clinical trial of glypizide].
D000284:Administration, Oral; D003510:Cyclohexanes / Q000008:administration & dosage / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D003925:Diabetic Angiopathies / Q000188:drug therapy; D003929:Diabetic Neuropathies / Q000188:drug therapy; D003930:Diabetic Retinopathy / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000008:administration & dosage / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D011719:Pyrazines; D013453:Sulfonylurea Compounds
Ensayo clínico de la glipizida.